1. Concord Biotech
stock logo

67% Buy

Concord Biotech Share Price

CONCORDBIO

₹2,079.30+₹74.55 (3.72%) TodayLast updated on 13 Sep, 2024 | 15:45 IST
Please wait...
  • News

  • Company overview

  • Fundamentals

  • Events

  • More

Company overview

Financial performance

arrow

Market cap

Market Cap Switch₹20,306 Crs

Open

₹2,000.00

Close

₹2,004.75

Circuit range

₹2,495.15 - ₹1,663.45

Day range

₹1,988.45 - ₹2,138.75

Year range

₹958.70 - ₹2,138.75

Volume

4,35,094

Avg. traded

₹2,088.93

Revenue (12m)

₹1,038 Crs

Concord BiotechConcord Biotech Limited is an India-based research and development driven biopharma company. The Company is engaged in the research and development, manufacturing, marketing, and selling of pharmaceutical products. The Company manufactures active pharmaceutical ingredients (API) through fermentation and semi-synthetic process and finished formulations. The Company’s offerings span both bio-pharmaceutical APIs and formulations across therapeutic areas like immunosuppressants oncology, anti-infectives nephrology, and critical care. Its portfolio also includes fermentation-based APIs in anti-bacterial, anti-fungal, and other therapeutic segments. Its API products include Mycophenolate Mofetil, Mycophenolate Sodium, Cyclosporine, Sirolimus, Pimecrolimus, Voclosporin, Mupirocin, Mupirocin Calcium, Vancomycin Hydrochloride, Teicoplanin, Polymyxin B Sulfate, Fidaxomicin, Anidulafungin. Its API products under development include Daptomycin, Epirubicin, Idarubicin, and Pirarubicin.

Concord Biotech Key indicators

arrow

52 week high

₹2,138.75

52 week low

₹958.70

P/E ratio

64.85

P/B ratio

12.81

ROE

21.63%

ROCE

28.89%

Dividend yield

0.48%

Debt/Equity ratio

EPS

29.13

Learn more

Investment checklist: (3/6)

arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Analyst ratings:

Buy

arrow

Buy

67%

Hold

33%

Sell

0%

This analysis is based on the reviews of 3 experts in the last 7 days

Fundamentals

Financial ratios

arrow
  • Profitability

  • Operational

  • Valuation

Operating profit margin

45.82%

Net profit margin

29.97%

ROE

21.63%

ROA

18.96%

ROCE

28.89%

Learn more

Concord Biotech Shareholder returns

arrow

1 day

+3.72%

1 week

+13.26%

1 month

+33.49%

3 months

+43.93%

1 year

+103.70%

3 years

+120.55%

5 years

+120.55%

Concord Biotech Share Price history

arrow
DayOpenCloseDay’s change
Fri, Sep 13 2024
₹2,000.00
₹2,079.30
+3.72%
Thu, Sep 12 2024
₹1,956.95
₹2,004.75
+3.28%
Wed, Sep 11 2024
₹1,897.65
₹1,941.00
+2.28%
Tue, Sep 10 2024
₹1,860.00
₹1,897.65
+2.33%
Mon, Sep 9 2024
₹1,829.95
₹1,854.40
+1.01%
Fri, Sep 6 2024
₹1,864.00
₹1,835.90
-0.96%
Thu, Sep 5 2024
₹1,800.00
₹1,853.70
+3.71%
Wed, Sep 4 2024
₹1,746.70
₹1,787.45
+1.06%

Shareholding info

arrow

Promoters (44.08%)

Mutual Funds (5.26%)

Retail and other (38.46%)

Foreign institutions-FII (7.11%)

Other domestic institutions (5.09%)

Promoters

Learn more

Events

Corporate actions

arrow
  • Dividend • ₹8.75/share

    Ex date 21 Jun 2024

    expand tab

Learn more

More

Frequently asked questions